|
2019 Conference Publication A population pharmacokinetic model of phenobarbitone in neonates to determine oral bioavailability and facilitate individualised dosingWilliams, A., Donovan, T., Charles, B. and Staatz, C. E. (2019). A population pharmacokinetic model of phenobarbitone in neonates to determine oral bioavailability and facilitate individualised dosing. Population Approach Group Australia and New Zealand, Adelaide, SA, Australia, February 2019. |
|
2019 Journal Article Investigating barriers to immunosuppressant medication adherence in renal transplant patientsCossart, Amelia R., Staatz, Christine E., Campbell, Scott B., Isbel, Nicole M. and Cottrell, W. Neil (2019). Investigating barriers to immunosuppressant medication adherence in renal transplant patients. Nephrology, 24 (1), 102-110. doi: 10.1111/nep.13214 |
|
2019 Conference Publication Utilisation of erythropoietin stimulating agents and immunosuppressants in chronic kidney disease patients.Stanley, K., Gardiner, K., Schultz, K. and Staatz, C. E. (2019). Utilisation of erythropoietin stimulating agents and immunosuppressants in chronic kidney disease patients.. Australian Pharmaceutical Sciences Association, Melbourne, Australia, December 2019. |
|
2019 Conference Publication A population pharmacokinetic model of phenobarbitone in neonates to determine oral bioavailability and facilitate individualised dosingWilliams, A., Donovan, T., Charles B. and Staatz, C. E. (2019). A population pharmacokinetic model of phenobarbitone in neonates to determine oral bioavailability and facilitate individualised dosing. European Society of Developmental, Perinatal and Paediatric Pharmacology Conference, Basel, Switzerland, 28-30 May 2019. |
|
2019 Conference Publication Effect of immunosuppressant prescribing patterns on patient outcomes in elderly Australasian kidney transplant recipientsCossart, A., Cottrell, N., Mcstea, M., Isbel, N., Campbell, S. and Staatz, C. E. (2019). Effect of immunosuppressant prescribing patterns on patient outcomes in elderly Australasian kidney transplant recipients. Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Queenstown, New Zealand, November 2019. |
|
2018 Journal Article Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life?Gardiner, Kyle M., Tett, Susan E. and Staatz, Christine E. (2018). Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life?. Drugs in R & D, 18 (4), 271-282. doi: 10.1007/s40268-018-0254-8 |
|
2018 Journal Article Prescription Opioid Fatalities: Examining Why the Healer Could be the CulpritAdewumi, Adeleke D., Staatz, Christine E., Hollingworth, Samantha A., Connor, Jason P. and Alati, Rosa (2018). Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit. Drug Safety, 41 (11), 1-11. doi: 10.1007/s40264-018-0687-6 |
|
2018 Journal Article Evaluation of Multiple Linear Regression Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant RecipientsBrooks, Emily K, Staatz, Christine E, Tett, Susan E, Isbel, Nicole M and McWhinney, Brett (2018). Evaluation of Multiple Linear Regression Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients. Therapeutic Drug Monitoring, 40 (2), 195-201. doi: 10.1097/FTD.0000000000000486 |
|
2018 Journal Article Comparison of methods to estimate glomerular filtration rate in paediatric oncology patientsLlanos-Paez, Carolina C., Staatz, Christine, Lawson, Rachael and Hennig, Stefanie (2018). Comparison of methods to estimate glomerular filtration rate in paediatric oncology patients. Journal of Paediatrics and Child Health, 54 (2), 141-147. doi: 10.1111/jpc.13752 |
|
2018 Conference Publication How are we using immunosuppressant medicines in Australasian elderly renal transplant recipients?Cossart A.,, Cottrell, N., Mcstea M.,, Isbel, N., Campbell, S. and Staatz, C. E. (2018). How are we using immunosuppressant medicines in Australasian elderly renal transplant recipients?. Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Adelaide, Australia, 27-30 November. |
|
2018 Conference Publication Immunosuppressant prescribing practices in younger adults compared to elderly renal transplant recipients across Australia and New ZealandCossart, A., Cottrell, N., Mcstea, M., Isbel, N., Campbell, S. and Staatz, C. E. (2018). Immunosuppressant prescribing practices in younger adults compared to elderly renal transplant recipients across Australia and New Zealand. Transplant Society of Australia and New Zealand conference, Melbourne, VIC Australia, 28 April - 1 May 2018. |
|
2018 Conference Publication How do body composition differences affect gentamicin therapy in pediatric patients?Llanos-Paez, Carolina, Staatz, Christine and Hennig, Stefanie (2018). How do body composition differences affect gentamicin therapy in pediatric patients?. ACoP9, Loews Coronado Bay, Coronado, CA, United States, 7-10 October 2018. New York, NY, United States: Springer. |
|
2018 Conference Publication Saliva mycophenolic acid monitoring following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients.Brooks, E., Tett, S. E., Isbel, N. M., McWhinney, B. and Staatz, C. E. (2018). Saliva mycophenolic acid monitoring following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients.. International Association of Therapeutic Drug Monitoring and Clinical Toxicology Brisbane, Brisbane, QLD Australia, 16-19 September 2018. |
|
2018 Conference Publication Examining immunosuppressant usage patterns in elderly Australasian renal transplant recipientsCossart, A., Cottrell, N., Mcstea, M., Isbel, N., Campbell, S. and Staatz, C. E. (2018). Examining immunosuppressant usage patterns in elderly Australasian renal transplant recipients. UQ 2018 Clinical and Public Health Symposium, Brisbane, QLD Australia, 22-23 November 2018. |
|
2018 Conference Publication Population pharmacokinetics of gentamicin in paediatrics: quantifying covariate-parameter relationships using the full random effects modelling (FREM) approachLlanos-Paez, Carolina , Staatz, Christine and Hennig, Stefanie (2018). Population pharmacokinetics of gentamicin in paediatrics: quantifying covariate-parameter relationships using the full random effects modelling (FREM) approach. 15th Annual Population Approach Group Australia and New Zealand Meeting (PAGANZ 2013), Melbourne, Australia, 5-7 February 2018. |
|
2018 Conference Publication Saliva prednisolone in adult kidney transplant recipients receiving triple therapy with tacrolimus, mycophenolate sodium and prednisoloneBrooks, E., Tett, S. E., Isbel, N. and Staatz, C. E. (2018). Saliva prednisolone in adult kidney transplant recipients receiving triple therapy with tacrolimus, mycophenolate sodium and prednisolone. RACP Trainee Research Awards, Brisbane, QLD Australia, 7 November 2018. |
|
2018 Conference Publication Evaluation of multiple linear regression limited sampling strategies for enteric-coated mycophenolate sodium in adult kidney transplant recipients.Brooks, E., Tett, S. E., Isbel, N. M., McWhinney, B. and Staatz, C. E. (2018). Evaluation of multiple linear regression limited sampling strategies for enteric-coated mycophenolate sodium in adult kidney transplant recipients.. American Transplant Congress, Seattle, WA United States, 2-6 June 2018. Hoboken, NJ United States: Wiley. |
|
2017 Journal Article Patterns in use and costs of subsidising 5-aminosalicyclic acid compounds and biologic agents in the treatment of inflammatory bowel disease in AustraliaStaatz, Christine E., Martin, Neal S., Kong, David P. and Hollingworth, Samantha A. (2017). Patterns in use and costs of subsidising 5-aminosalicyclic acid compounds and biologic agents in the treatment of inflammatory bowel disease in Australia. Digestive and Liver Disease, 50 (3), 314-317. doi: 10.1016/j.dld.2017.12.016 |
|
2017 Journal Article Patterns in use and costs of conventional and biologic disease-modifying anti-rheumatic drugs in AustraliaDonges, E., Staatz, C. E., Benham, H., Kubler, P. and Hollingworth, S. A. (2017). Patterns in use and costs of conventional and biologic disease-modifying anti-rheumatic drugs in Australia. Clinical and Experimental Rheumatology, 35 (6), 907-912. |
|
2017 Journal Article Balancing Antibacterial Efficacy and Reduction in Renal Function to Optimise Initial Gentamicin Dosing in Paediatric Oncology PatientsLlanos-Paez, Carolina Consuelo, Staatz, Christine and Hennig, Stefanie (2017). Balancing Antibacterial Efficacy and Reduction in Renal Function to Optimise Initial Gentamicin Dosing in Paediatric Oncology Patients. AAPS Journal, 20 (1) 14, 1-9. doi: 10.1208/s12248-017-0173-6 |
